Extracorporeal blood purification with polymyxin B immobilized fiber column direct
hemoperfusion (PMX-DHP), is reported to be effective in treating COVID-19 pneumonitis …

Purpose The characteristics of patients with severe COVID-19 pneumonia who underwent
direct hemoperfusion using polymyxin B-immobilized fiber column (PMX-DHP), in addition to …

Objective To evaluate the efficacy and safety of direct hemoperfusion using a polymyxin B‐
immobilized polystyrene column (PMX‐DHP) in severe acute respiratory syndrome …

Background: Polymyxin B-immobilized fiber column (PMX; Toraymyxin column) was
approved for the relief of systemic inflammatory response syndrome caused by bacterial …

An 83-year-old man was hospitalized for coronavirus disease 2019 (COVID-19) after a 10-
day history of a persistent fever. Chest computed tomography showed extensive non …

Abstract The coronavirus disease 2019 (COVID‐19) has been shown to involve the
gastrointestinal tract, which implies bacterial translocation and endotoxemia. The aim of this …

When should polymyxin B-immobilized polystyrene column be introduced to improve COVID-
19 prognosis? Recently, we measured EAA before and after PMX-DHP in COVID-19 …

Introduction: Systematic inflammatory response occurred in some critically ill patients with
COVID-19. Cytokine reduction by hemadsorption is a mechanism of treatment. However …

Abstract Background Coronavirus disease‐19 (COVID‐19) ranges from asymptomatic
infection to severe cases requiring admission to the intensive care unit. Together with …

Introduction: Currently, the effect of hemoperfusion on outcome in severe COVID-19 patients
is still unknown. Therefore, we aimed to investigate the effects of early HA-330 …